These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12604156)

  • 1. Coxibs--beyond the GI tract: renal and cardiovascular issues.
    DeMaria AN; Weir MR
    J Pain Symptom Manage; 2003 Feb; 25(2 Suppl):S41-9. PubMed ID: 12604156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspective on the cardiovascular effects of coxibs.
    Konstam MA; Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global safety of coxibs and NSAIDs.
    Pham K; Hirschberg R
    Curr Top Med Chem; 2005; 5(5):465-73. PubMed ID: 15974941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries?
    Warden SJ
    Sports Med; 2005; 35(4):271-83. PubMed ID: 15831058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based evaluation of the gastrointestinal safety of coxibs.
    Bombardier C
    Am J Cardiol; 2002 Mar; 89(6A):3D-9D. PubMed ID: 11909555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of cyclooxygyenase-2-selective inhibitors.
    Brater DC
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.
    Lehmann FS; Beglinger C
    Curr Top Med Chem; 2005; 5(5):449-64. PubMed ID: 15974940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibitors and the cardiovascular system.
    FitzGerald GA; Cheng Y; Austin S
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S31-6. PubMed ID: 11695249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and renal damage.
    Navarro JF
    J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal safety of selective COX-2 inhibitors.
    Hawkey CJ; Skelly MM
    Curr Pharm Des; 2002; 8(12):1077-89. PubMed ID: 11945152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the cardiovascular safety of COXIBs compared to NSAIDS.
    Moodley I
    Cardiovasc J Afr; 2008; 19(2):102-7. PubMed ID: 18516356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs.
    Laine L; Wogen J; Yu H
    Gastroenterology; 2003 Aug; 125(2):389-95. PubMed ID: 12891540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity].
    Ruilope LM; Coca A
    Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.